Analystreport

The Medicines Company (NASDAQ: MDCO) had its "buy" rating re-affirmed by analysts at Leerink Swann.

MEDICINES  (MDCO) 
Last medicines earnings: 10/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: themedicinescompany.com/investors